Skip to main content
Clinical Trials/NCT00924222
NCT00924222CompletedNot Applicable

Organ Protection With Sevoflurane Postconditioning After Cardiac Surgery With Cardiopulmonary Bypass

University of Zurich0 sites120 target enrollmentStarted: October 2007Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
120
Primary Endpoint
Myocardial injury markers (myoglobin, creatine kinase, myocard specific creatine kinase, and troponin T)

Study Overview

Brief Summary

Organ protection, volatile anesthetics, postconditioning.

Sedation of patients on ICU after cardiac surgery with cardiopulmonary bypass with either propofol or sevoflurane. Evaluation of organ function and inflammatory mediators in the blood.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Sevoflurane

Experimental

Intervention: Sevoflurane (Drug)

Sevoflurane

Experimental

Intervention: Propofol (Drug)

Propofol

Experimental

Intervention: Sevoflurane (Drug)

Propofol

Experimental

Intervention: Propofol (Drug)

Outcomes

Primary Outcomes

Myocardial injury markers (myoglobin, creatine kinase, myocard specific creatine kinase, and troponin T)

Time Frame: Start and end of ICU stay

Secondary Outcomes

  • Oxygenation index, postoperative pulmonary complications, ICU stay (days), length of hospitalisation(Start with surgery until end of hospitalisation)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials